Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan ...
Journal of Bioresources and Bioproducts reports that a phenol-rich, low-molecular lignin fraction (F3) obtained by simple ...
Learn why genetic mutation testing should be the first step in cancer diagnosis and how it leads to precise, life-saving ...
The Atopic Dermatitis Pipeline Report provides disease overview, pipeline scenario and therapeutic assessment of the key ...
Interleukin-1 receptor-associated kinase 4 (IRAK-4) is a modulator of IL-1 receptor and Toll-like receptor (TLR) signaling and has emerged as a promising therapeutic target for several inflammatory ...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...
The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after ...
In a new study, scientists have shown that chemical receptors that plants use to recognize nitrogen-fixing bacteria have ...
Elderberry juice intake triggers metabolic gene expression changes, enhancing glucose control and fat oxidation in overweight ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...